Paul Clayton

Paul Clayton, PhD, is a Visiting Professor at the Institute of Interdisciplinary Medicine in Moscow, where they focus on creating decentralized, food-based health care systems. Currently serving as the Chief Scientific Advisor at GenCor Pacific and Zinzino, they also hold leadership positions on multiple scientific advisory boards, including at PHARMACTIVE BIOTECH PRODUCTS and BioActive Foods AS. Previously, Paul contributed as Chief Scientific Officer at Biogenics and has been involved with various academic and innovation boards, including the Medical Academy of the Russian Federation. Paul earned a PhD in Clinical Pharmacology from Edinburgh University and has shared their expertise as a visiting professor at the University of Pecs.